Literature DB >> 26577296

A practical approach to diseases affecting dentate nuclei.

S Khadilkar1, S Jaggi2, B Patel3, R Yadav3, P Hanagandi4, L L Faria do Amaral5.   

Abstract

A wide variety of diseases affect the dentate nuclei. When faced with the radiological demonstration of signal changes in the dentate nuclei, radiologists and clinical neurologists have to sieve through the many possibilities, which they do not encounter on a regular basis. This task can be challenging, and therefore, developing a clinical, radiological, and laboratory approach is important. Information on the topic is scattered and the subject has not yet been reviewed. In this review, a combined clinicoradiological approach is presented. The signal changes in T1, T2, fluid-attenuated inversion recovery (FLAIR), diffusion, susceptibility weighted, and gadolinium-enhanced images can give specific or highly suggestive patterns, which are illustrated. The role of computed tomography (CT) in the diagnostic process is discussed. Specific radiological patterns do not exist in a significant proportion of patients where the clinical and laboratory analysis becomes important. In this review, we group the clinical constellations to narrow down the differential diagnosis and highlight the diagnostic clinical signs, such as tendon xanthomas and Kayser-Fleischer rings. As will be seen, a number of these conditions are potentially reversible, and hence, their early diagnosis is desirable. Finally, key diagnostic tests and available therapies are outlined. The practical approach thus begins with the radiologist and winds its way through the clinician, towards carefully selected diagnostic tests defining the therapy options.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26577296     DOI: 10.1016/j.crad.2015.09.010

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

2.  A Case of Isoniazid Induced Cerebellitis in a Patient with Chronic Renal Failure.

Authors:  Vaishal Sanjaybhai Shah; Vijay Sardana
Journal:  Ann Indian Acad Neurol       Date:  2020-06-05       Impact factor: 1.383

Review 3.  Movement Disorders Associated with Hypogonadism.

Authors:  Paulina Gonzalez-Latapi; Mario Sousa; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2021-07-29

4.  The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.

Authors:  Cyprian Olchowy; Kamil Cebulski; Mateusz Łasecki; Radosław Chaber; Anna Olchowy; Krzysztof Kałwak; Urszula Zaleska-Dorobisz
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

5.  Imaging of dentate nucleus pathologies; a pictorial essay.

Authors:  Kajari Bhattacharya; Hima Pendharkar; Arun K Gupta
Journal:  Indian J Radiol Imaging       Date:  2018 Apr-Jun

6.  Short-Course Self-Medication of Metronidazole Leading to Acute Toxic Encephalopathy and Ataxia.

Authors:  Yatin Sagvekar; Virti Shah; Anshu Rohatgi; Neha Pandita; Rahul Sharma; Rajeswari Rajan; Dhrumil Shah
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

7.  Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.

Authors:  Tanja Schmitz-Hübsch; Silke Lux; Peter Bauer; Alexander U Brandt; Elena Schlapakow; Susanne Greschus; Michael Scheel; Hanna Gärtner; Mehmet E Kirlangic; Vincent Gras; Dagmar Timmann; Matthis Synofzik; Alejandro Giorgetti; Paolo Carloni; Jon N Shah; Ludger Schöls; Ute Kopp; Lisa Bußenius; Timm Oberwahrenbrock; Hanna Zimmermann; Caspar Pfueller; Ella-Maria Kadas; Maria Rönnefarth; Anne-Sophie Grosch; Matthias Endres; Katrin Amunts; Friedemann Paul; Sarah Doss; Martina Minnerop
Journal:  Ann Clin Transl Neurol       Date:  2021-03-19       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.